Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764130011 | Dolasetron mesilate 20 mg powder for solution for injection ampoule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3764131010 | Dolasetron mesylate 20 mg powder for solution for injection ampule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3764132015 | Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | Product containing dolasetron | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has active ingredient | Dolasetron | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | Product containing dolasetron in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has active ingredient | Dolasetron mesilate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | Product containing only dolasetron in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit | Ampule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Dolasetron mesilate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | Dolasetron mesilate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Ampule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Plays role | Antiemetic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR